CSX financials
$46.93+0.36%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.09B | $14.54B | $14.66B | $14.85B | $12.52B | $10.58B | $11.94B | $12.25B | $11.41B | $11.07B |
| Gross profit | $14.09B | $14.54B | $14.66B | $14.85B | $12.52B | $10.58B | $11.94B | $12.25B | $11.41B | $11.07B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $4.52B | $5.25B | $5.50B | $5.72B | $5.14B | $4.33B | $4.81B | $4.87B | $3.50B | $3.36B |
| Net income | $2.89B | $3.47B | $3.67B | $4.11B | $3.78B | $2.77B | $3.33B | $3.31B | $5.47B | $1.71B |
| Net margin | 20.5% | 23.9% | 25.0% | 27.7% | 30.2% | 26.1% | 27.9% | 27.0% | 48.0% | 15.5% |
| Diluted EPS | $1.54 | $1.79 | $1.82 | $1.92 | $1.68 | $1.20 | $1.39 | $1.28 | $2.00 | $0.60 |
| EBITDA | $6.37B | $7.01B | $7.11B | $7.22B | $6.56B | $5.71B | $6.16B | $6.20B | $5.06B | $4.66B |
| Operating cash flow | $4.61B | $5.25B | $5.51B | $5.53B | $5.10B | $4.26B | $4.85B | $4.64B | $3.47B | $3.04B |
| Free cash flow | $1.71B | $2.72B | $3.26B | $3.41B | $3.31B | $2.64B | $3.19B | $2.90B | $1.43B | $643.0M |
| Diluted shares | 1,873.0M | 1,943.0M | 2,013.0M | 2,141.0M | 2,255.0M | 2,305.0M | 2,395.0M | 2,583.0M | 2,742.0M | 2,844.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $670.0M | $933.0M | $1.35B | $1.96B | $2.24B | $3.13B |
| Short-term investments | $5.0M | $72.0M | $83.0M | $129.0M | $77.0M | $2.0M |
| Total debt | $19.04B | $18.68B | $18.53B | $18.05B | $16.37B | $16.70B |
| Total assets | $43.68B | $42.76B | $42.21B | $41.91B | $40.53B | $39.79B |
| Total liabilities | $30.52B | $30.26B | $30.23B | $29.29B | $27.03B | $26.68B |
| Shareholders' equity | $13.16B | $12.51B | $11.98B | $12.63B | $13.50B | $13.11B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology